1
|
Artola M, Aerts JMFG, van der Marel GA, Rovira C, Codée JDC, Davies GJ, Overkleeft HS. From Mechanism-Based Retaining Glycosidase Inhibitors to Activity-Based Glycosidase Profiling. J Am Chem Soc 2024; 146:24729-24741. [PMID: 39213505 PMCID: PMC11403624 DOI: 10.1021/jacs.4c08840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/04/2024]
Abstract
Activity-based protein profiling (ABPP) is an effective technology for the identification and functional annotation of enzymes in complex biological samples. ABP designs are normally directed to an enzyme active site nucleophile, and within the field of Carbohydrate-Active Enzymes (CAZymes), ABPP has been most successful for those enzymes that feature such a residue: retaining glycosidases (GHs). Several mechanism-based covalent and irreversible retaining GH inhibitors have emerged over the past sixty years. ABP designs based on these inhibitor chemistries appeared since the turn of the millennium, and we contributed to the field by designing a suite of retaining GH ABPs modeled on the structure and mode of action of the natural product, cyclophellitol. These ABPs enable the study of both exo- and endo-acting retaining GHs in human health and disease, for instance in genetic metabolic disorders in which retaining GHs are deficient. They are also finding increasing use in the study of GHs in gut microbiota and environmental microorganisms, both in the context of drug (de)toxification in the gut and that of biomass polysaccharide processing for future sustainable energy and chemistries. This account comprises the authors' view on the history of mechanism-based retaining GH inhibitor design and discovery, on how these inhibitors served as blueprints for retaining GH ABP design, and on some current and future developments on how cyclophellitol-based ABPs may drive the discovery of retaining GHs and their inhibitors.
Collapse
Affiliation(s)
- Marta Artola
- Leiden Institute of Chemistry, Leiden University, 2300 RA, Leiden, The Netherlands
| | - Johannes M F G Aerts
- Leiden Institute of Chemistry, Leiden University, 2300 RA, Leiden, The Netherlands
| | | | - Carme Rovira
- Departament de Química Inorgànica I Orgànica & IQTCUB, Universitat de Barcelona, Barcelona 08028, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08020, Spain
| | - Jeroen D C Codée
- Leiden Institute of Chemistry, Leiden University, 2300 RA, Leiden, The Netherlands
| | - Gideon J Davies
- Department of Chemistry, The University York, Heslington, York YO10 5DD, United Kingdom
| | - Herman S Overkleeft
- Leiden Institute of Chemistry, Leiden University, 2300 RA, Leiden, The Netherlands
| |
Collapse
|
2
|
Lohith TG, Kaittanis C, Belanger AP, Ahn SH, Sandoval P, Cohen L, Rajarshi G, Ruangsiriluk W, Islam R, Winkelmann CT, McQuade P. Radiosynthesis and Early Evaluation of a Positron Emission Tomography Imaging Probe [ 18F]AGAL Targeting Alpha-Galactosidase A Enzyme for Fabry Disease. Molecules 2023; 28:7144. [PMID: 37894622 PMCID: PMC10609273 DOI: 10.3390/molecules28207144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 10/12/2023] [Accepted: 10/13/2023] [Indexed: 10/29/2023] Open
Abstract
Success of gene therapy relies on the durable expression and activity of transgene in target tissues. In vivo molecular imaging approaches using positron emission tomography (PET) can non-invasively measure magnitude, location, and durability of transgene expression via direct transgene or indirect reporter gene imaging in target tissues, providing the most proximal PK/PD biomarker for gene therapy trials. Herein, we report the radiosynthesis of a novel PET tracer [18F]AGAL, targeting alpha galactosidase A (α-GAL), a lysosomal enzyme deficient in Fabry disease, and evaluation of its selectivity, specificity, and pharmacokinetic properties in vitro. [18F]AGAL was synthesized via a Cu-catalyzed click reaction between fluorinated pentyne and an aziridine-based galactopyranose precursor with a high yield of 110 mCi, high radiochemical purity of >97% and molar activity of 6 Ci/µmol. The fluorinated AGAL probe showed high α-GAL affinity with IC50 of 30 nM, high pharmacological selectivity (≥50% inhibition on >160 proteins), and suitable pharmacokinetic properties (moderate to low clearance and stability in plasma across species). In vivo [18F]AGAL PET imaging in mice showed high uptake in peripheral organs with rapid renal clearance. These promising results encourage further development of this PET tracer for in vivo imaging of α-GAL expression in target tissues affected by Fabry disease.
Collapse
Affiliation(s)
- Talakad G. Lohith
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Charalambos Kaittanis
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Anthony P. Belanger
- Molecular Cancer Imaging Facility, Dana Farber Cancer Institute, Boston, MA 02210, USA; (A.P.B.); (S.H.A.)
| | - Shin Hye Ahn
- Molecular Cancer Imaging Facility, Dana Farber Cancer Institute, Boston, MA 02210, USA; (A.P.B.); (S.H.A.)
| | - Phil Sandoval
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Lawrence Cohen
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Girija Rajarshi
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Wanida Ruangsiriluk
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Rizwana Islam
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Christopher T. Winkelmann
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| | - Paul McQuade
- Takeda Pharmaceutical Co., Ltd., Cambridge, MA 02142, USA; (C.K.); (P.S.); (L.C.); (G.R.); (W.R.); (R.I.); (C.T.W.); (P.M.)
| |
Collapse
|
3
|
Kuo CL, Su Q, van den Nieuwendijk AMCH, Beenakker TJM, Offen WA, Willems LI, Boot RG, Sarris AJ, Marques ARA, Codée JDC, van der Marel GA, Florea BI, Davies GJ, Overkleeft HS, Aerts JMFG. The development of a broad-spectrum retaining β-exo-galactosidase activity-based probe. Org Biomol Chem 2023; 21:7813-7820. [PMID: 37724332 DOI: 10.1039/d3ob01261a] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/20/2023]
Abstract
Acid β-galactosidase (GLB1) and galactocerebrosidase (GALC) are retaining exo-β-galactosidases involved in lysosomal glycoconjugate metabolism. Deficiency of GLB1 may result in the lysosomal storage disorders GM1 gangliosidosis, Morquio B syndrome, and galactosialidosis, and deficiency of GALC may result in Krabbe disease. Activity-based protein profiling (ABPP) is a powerful technique to assess the activity of retaining glycosidases in relation to health and disease. This work describes the use of fluorescent and biotin-carrying activity-based probes (ABPs) to assess the activity of both GLB1 and GALC in cell lysates, culture media, and tissue extracts. The reported ABPs, which complement the growing list of retaining glycosidase ABPs based on configurational isomers of cyclophellitol, should assist in fundamental and clinical research on various β-galactosidases, whose inherited deficiencies cause debilitating lysosomal storage disorders.
Collapse
Affiliation(s)
- Chi-Lin Kuo
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Qin Su
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | | | - Thomas J M Beenakker
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Wendy A Offen
- Department of Chemistry, University of York, Heslington, York, YO10 5DD York, UK
| | - Lianne I Willems
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
- Department of Chemistry, University of York, Heslington, York, YO10 5DD York, UK
| | - Rolf G Boot
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Alexi J Sarris
- Bioorganic Synthesis group, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - André R A Marques
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Jeroen D C Codée
- Bioorganic Synthesis group, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Gijsbert A van der Marel
- Bioorganic Synthesis group, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Bogdan I Florea
- Bioorganic Synthesis group, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Gideon J Davies
- Department of Chemistry, University of York, Heslington, York, YO10 5DD York, UK
| | - Herman S Overkleeft
- Bioorganic Synthesis group, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| | - Johannes M F G Aerts
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, P. O. Box 9502, 2300 RA Leiden, The Netherlands.
| |
Collapse
|
4
|
Borràs-Tudurí R, Alcaide A, Aspeslag S, Usero L, Serra C, Roura-Mir C, Elewaut D, Llebaria A. New Paradigm in NKT Cell Antigens: MCS-0208 (2-(Hydroxymethyl)phenylthio-phytoceramide) - an Aryl-Phytoceramide Compound with a Single Hydroxyl Group Stimulates NKT Cells. ChemMedChem 2021; 16:2491-2496. [PMID: 33821540 PMCID: PMC8453509 DOI: 10.1002/cmdc.202000992] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Revised: 03/10/2021] [Indexed: 11/07/2022]
Abstract
Natural Killer T (NKT) cells play an important role in the immune response and can be activated by glycolipids presented by CD1d protein. We present MCS‐0208, an unprecedented arylthioether‐phytoceramide able to induce potent invariant NKT (iNKT) cell activation, notably when tested in human iNKT cells. This arylsphingolipid analog has a simple phenyl group containing a single hydroxyl substituent as a surrogate of the sugar ring. The phenylthioether structure contrasts with α‐galactosylceramide (1), the prototypical glycolipid used to induce iNKT cell stimulation, where the galactose 2’‐OH and 3’‐OH substituents are accepted as the minimal footprint and considered critical for NKT T cell receptor (TCR) recognition. A computational study supports the recognition of aromatic compound by the CD1d and TCR proteins as radically new structures for NKT cell stimulation.
Collapse
Affiliation(s)
- Roser Borràs-Tudurí
- Medicinal Chemistry and Synthesis (MCS) Laboratory, Institut de Química Avançada de Catalunya (IQAC) Consejo Superior de Investigaciones Científicas (CSIC), C/ Jordi Girona 18-26, 08034, Barcelona, Spain
| | - Anna Alcaide
- Medicinal Chemistry and Synthesis (MCS) Laboratory, Institut de Química Avançada de Catalunya (IQAC) Consejo Superior de Investigaciones Científicas (CSIC), C/ Jordi Girona 18-26, 08034, Barcelona, Spain
| | - Sandrine Aspeslag
- Unit for Molecular Immunology and Inflammation, VIB-Center for Inflammation Research, Ghent, Belgium.,Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
| | - Lorena Usero
- Laboratori d'Immunologia Cel⋅lular Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona Bellaterra, 08193, Barcelona, Spain
| | - Carmen Serra
- Medicinal Chemistry and Synthesis (MCS) Laboratory, Institut de Química Avançada de Catalunya (IQAC) Consejo Superior de Investigaciones Científicas (CSIC), C/ Jordi Girona 18-26, 08034, Barcelona, Spain
| | - Carme Roura-Mir
- Laboratori d'Immunologia Cel⋅lular Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona Bellaterra, 08193, Barcelona, Spain
| | - Dirk Elewaut
- Unit for Molecular Immunology and Inflammation, VIB-Center for Inflammation Research, Ghent, Belgium.,Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
| | - Amadeu Llebaria
- Medicinal Chemistry and Synthesis (MCS) Laboratory, Institut de Química Avançada de Catalunya (IQAC) Consejo Superior de Investigaciones Científicas (CSIC), C/ Jordi Girona 18-26, 08034, Barcelona, Spain
| |
Collapse
|
5
|
Široký M, Gonda J, Martinková M, Jacková D, Vilková M, Bindzár V, Kuchár J, Šesták S. Synthesis and mannosidase inhibitory profile of a small library of aminocyclitols from shikimic acid-derived scaffolds. Carbohydr Res 2020; 493:108027. [DOI: 10.1016/j.carres.2020.108027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Revised: 04/28/2020] [Accepted: 04/28/2020] [Indexed: 12/18/2022]
|
6
|
Abstract
Background:
Immunomodulation-based therapy has achieved a breakthrough in
the last decade, which stimulates the passion of searching for potential immunomodulatory
substances in recent years.
Objective:
Marine natural products are a unique source of immunomodulatory substances.
This paper summarized the emerging marine natural small-molecules and related synthesized
derivatives with immunomodulatory activities to provide readers an overview of these bioactive
molecules and their potential in immunomodulation therapy.
Conclusion:
An increasing number of immunomodulatory marine small-molecules with diverse
intriguing structure-skeletons were discovered. They may serve as a basis for further
studies of marine natural products for their chemistry, related mechanism of action and structure-
activity relationships.
Collapse
Affiliation(s)
- Ran Li
- School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Yu-Cheng Gu
- Syngenta, Jealott’s Hill International Research Centre, Bracknell, Berkshire RG42 6EY, United Kingdom
| | - Wen Zhang
- School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| |
Collapse
|
7
|
Sánchez-Fernández EM, García-Moreno MI, Arroba AI, Aguilar-Diosdado M, Padrón JM, García-Hernández R, Gamarro F, Fustero S, Sánchez-Aparicio JE, Masgrau L, García Fernández JM, Ortiz Mellet C. Synthesis of polyfluoroalkyl sp 2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies. Eur J Med Chem 2019; 182:111604. [PMID: 31425910 DOI: 10.1016/j.ejmech.2019.111604] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Revised: 07/27/2019] [Accepted: 08/07/2019] [Indexed: 12/27/2022]
Abstract
Immunomodulatory glycolipids, among which α-galactosylceramide (KRN7000) is an iconic example, have shown strong therapeutic potential in a variety of conditions ranging from cancer and infection to autoimmune or neurodegenerative diseases. A main difficulty for those channels is that they often provoke a cytokine storm comprising both pro- and anti-inflammatory mediators that antagonize each other and negatively affect the immune response. The synthesis of analogues with narrower cytokine secretion-inducing capabilities is hampered by the intrinsic difficulty at controlling the stereochemical outcome in glycosidation reactions, particularly if targeting the α-anomer, which seriously hampers drug optimization strategies. Here we show that replacing the monosaccharide glycone by a sp2-iminosugar glycomimetic moiety allows accessing N-linked sp2-iminosugar glycolipids (sp2-IGLs) with total α-stereocontrol in a single step with no need of protecting groups or glycosidation promotors. The lipid tail has been then readily tailored by incorporating polyfluoroalkyl segments of varied lengths in view of favouring binding to the lipid binding site of the master p38 mitogen activated protein kinase (p38 MAPK), thereby polarizing the immune response in a cell-context dependent manner. The compounds have been evaluated for their antiproliferative, anti-leishmanial and anti-inflammatory activities in different cell assays. The size of the fluorous segment was found to be critical for the biological activity, probably by regulating the aggregation and membrane-crossing properties, whereas the hydroxylation profile (gluco or galacto-like) was less relevant. Biochemical and computational data further support a mechanism of action implying binding to the allosteric lipid binding site of p38 MAPK and subsequent activation of the noncanonical autophosphorylation route. The ensemble of results provide a proof of concept of the potential of sp2-IGLs as immunoregulators.
Collapse
Affiliation(s)
- Elena M Sánchez-Fernández
- Department of Organic Chemistry, Faculty of Chemistry, University of Seville, C/ Profesor García González 1, 41012, Seville, Spain.
| | - Ma Isabel García-Moreno
- Department of Organic Chemistry, Faculty of Chemistry, University of Seville, C/ Profesor García González 1, 41012, Seville, Spain
| | - Ana I Arroba
- Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, Av/ Ana de Viya 21, 11009, Cádiz, Spain; Research Unit, Jerez University Hospital, Carretera Circunvalación s/n, 11407, Jerez de la Frontera, Spain.
| | - Manuel Aguilar-Diosdado
- Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, Av/ Ana de Viya 21, 11009, Cádiz, Spain; Research Unit, Jerez University Hospital, Carretera Circunvalación s/n, 11407, Jerez de la Frontera, Spain
| | - José M Padrón
- BioLab, Instituto Universitario de Bio-Orgánica "Antonio González" (IUBO AG), Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de la Laguna, PO BOX 456, 38200, La Laguna, Spain
| | - Raquel García-Hernández
- Instituto de Parasitología y Biomedicina "López Neyra", IPBLN-CSIC, Parque Tecnológico de Ciencias de la Salud, 18016, Granada, Spain
| | - Francisco Gamarro
- Instituto de Parasitología y Biomedicina "López Neyra", IPBLN-CSIC, Parque Tecnológico de Ciencias de la Salud, 18016, Granada, Spain
| | - Santos Fustero
- Department of Organic Chemistry, Universidad de Valencia, 46100, Burjassot, Spain
| | | | - Laura Masgrau
- Department of Chemistry, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain
| | - José Manuel García Fernández
- Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, C/ Américo Vespucio 49, Isla de la Cartuja, 41092, Sevilla, Spain
| | - Carmen Ortiz Mellet
- Department of Organic Chemistry, Faculty of Chemistry, University of Seville, C/ Profesor García González 1, 41012, Seville, Spain.
| |
Collapse
|
8
|
Artola M, Wouters S, Schröder SP, de Boer C, Chen Y, Petracca R, van den Nieuwendijk AMCH, Aerts JMFG, van der Marel GA, Codée JDC, Overkleeft HS. Direct Stereoselective Aziridination of Cyclohexenols with 3-Amino-2-(trifluoromethyl)quinazolin-4(3 H)-one in the Synthesis of Cyclitol Aziridine Glycosidase Inhibitors. European J Org Chem 2019; 2019:1397-1404. [PMID: 31787842 PMCID: PMC6876648 DOI: 10.1002/ejoc.201801703] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2018] [Indexed: 11/08/2022]
Abstract
Cyclophellitol aziridine and its configurational and functional isomers are powerful covalent inhibitors of retaining glycosidases, and find application in fundamental studies on glycosidases, amongst others in relation to inherited lysosomal storage disorders caused by glycosidase malfunctioning. Few direct and stereoselective aziridination methodologies are known for the synthesis of cyclophellitol aziridines. Herein, we present our studies on the scope of direct 3‐amino‐2‐(trifluoromethyl)quinazolin‐4(3H)‐one‐mediated aziridination on a variety of configurational and functional cyclohexenol isosters. We demonstrate that the aziridination can be directed by an allylic or homoallylic hydroxyl through H‐bonding and that steric hindrance plays a key role in the diastereoselectivity of the reaction.
Collapse
Affiliation(s)
- Marta Artola
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Shirley Wouters
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Sybrin P Schröder
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Casper de Boer
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Yurong Chen
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Rita Petracca
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | | | - Johannes M F G Aerts
- Department of Medical Biochemistry Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Gijsbert A van der Marel
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Jeroen D C Codée
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Herman S Overkleeft
- Department of Bio-organic Synthesis Leiden Institute of Chemistry Leiden University Einsteinweg 55 2333 CC Leiden The Netherlands
| |
Collapse
|
9
|
Tukhvatshin RS, Kucherenko AS, Nelyubina YV, Zlotin SG. Stereoselective Synthesis of Tetrahydroquinolines via Asymmetric Domino Reaction Catalyzed by a Recyclable Ionic-Liquid-Supported Bifunctional Tertiary Amine. European J Org Chem 2018. [DOI: 10.1002/ejoc.201801423] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Rinat S. Tukhvatshin
- N.D. Zelinsky Institute of Organic Chemistry; Russian Academy of Sciences; 47 Leninsky Prospect 119991 Moscow Russian Federation
| | - Alexander S. Kucherenko
- N.D. Zelinsky Institute of Organic Chemistry; Russian Academy of Sciences; 47 Leninsky Prospect 119991 Moscow Russian Federation
| | - Yulia V. Nelyubina
- A.N. Nesmeyanov Institute of Organoelement Compounds; Russian Academy of Sciences; 28, Vavilova str 119991 Moscow Russia
| | - Sergei G. Zlotin
- N.D. Zelinsky Institute of Organic Chemistry; Russian Academy of Sciences; 47 Leninsky Prospect 119991 Moscow Russian Federation
| |
Collapse
|
10
|
Artola M, Kuo CL, McMahon SA, Oehler V, Hansen T, van der Lienden M, He X, van den Elst H, Florea BI, Kermode AR, van der Marel GA, Gloster TM, Codée JDC, Overkleeft HS, Aerts JMFG. New Irreversible α-l-Iduronidase Inhibitors and Activity-Based Probes. Chemistry 2018; 24:19081-19088. [PMID: 30307091 PMCID: PMC6343074 DOI: 10.1002/chem.201804662] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Revised: 10/10/2018] [Indexed: 11/20/2022]
Abstract
Cyclophellitol aziridines are potent irreversible inhibitors of retaining glycosidases and versatile intermediates in the synthesis of activity‐based glycosidase probes (ABPs). Direct 3‐amino‐2‐(trifluoromethyl)quinazolin‐4(3H)‐one‐mediated aziridination of l‐ido‐configured cyclohexene has enabled the synthesis of new covalent inhibitors and ABPs of α‐l‐iduronidase, deficiency of which underlies the lysosomal storage disorder mucopolysaccharidosis type I (MPS I). The iduronidase ABPs react covalently and irreversibly in an activity‐based manner with human recombinant α‐l‐iduronidase (rIDUA, Aldurazyme®). The structures of IDUA when complexed with the inhibitors in a non‐covalent transition state mimicking form and a covalent enzyme‐bound form provide insights into its conformational itinerary. Inhibitors 1–3 adopt a half‐chair conformation in solution (4H3 and 3H4), as predicted by DFT calculations, which is different from the conformation of the Michaelis complex observed by crystallographic studies. Consequently, 1–3 may need to overcome an energy barrier in order to switch from the 4H3 conformation to the transition state (2, 5B) binding conformation before reacting and adopting a covalent 5S1 conformation. rIDUA can be labeled with fluorescent Cy5 ABP 2, which allows monitoring of the delivery of therapeutic recombinant enzyme to lysosomes, as is intended in enzyme replacement therapy for the treatment of MPS I patients.
Collapse
Affiliation(s)
- Marta Artola
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Chi-Lin Kuo
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Stephen A McMahon
- Biomedical Sciences Research Complex, School of Biology, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK
| | - Verena Oehler
- Biomedical Sciences Research Complex, School of Biology, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK
| | - Thomas Hansen
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Martijn van der Lienden
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Xu He
- Department of Biological Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada
| | - Hans van den Elst
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Bogdan I Florea
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Allison R Kermode
- Department of Biological Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada
| | - Gijsbert A van der Marel
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Tracey M Gloster
- Biomedical Sciences Research Complex, School of Biology, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK
| | - Jeroen D C Codée
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Herman S Overkleeft
- Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| | - Johannes M F G Aerts
- Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands
| |
Collapse
|
11
|
Schröder SP, Wu L, Artola M, Hansen T, Offen WA, Ferraz MJ, Li KY, Aerts JMFG, van der Marel GA, Codée JDC, Davies GJ, Overkleeft HS. Gluco-1 H-imidazole: A New Class of Azole-Type β-Glucosidase Inhibitor. J Am Chem Soc 2018; 140:5045-5048. [PMID: 29601200 PMCID: PMC5942873 DOI: 10.1021/jacs.8b02399] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Gluco-azoles competitively inhibit glucosidases by transition-state mimicry and their ability to interact with catalytic acid residues in glucosidase active sites. We noted that no azole-type inhibitors described, to date, possess a protic nitrogen characteristic for 1 H-imidazoles. Here, we present gluco-1 H-imidazole, a gluco-azole bearing a 1 H-imidazole fused to a glucopyranose-configured cyclitol core, and three close analogues as new glucosidase inhibitors. All compounds inhibit human retaining β-glucosidase, GBA1, with the most potent ones inhibiting this enzyme (deficient in Gaucher disease) on a par with glucoimidazole. None inhibit glucosylceramide synthase, cytosolic β-glucosidase GBA2 or α-glucosidase GAA. Structural, physical and computational studies provide first insights into the binding mode of this conceptually new class of retaining β-glucosidase inhibitors.
Collapse
Affiliation(s)
| | - Liang Wu
- Department of Chemistry, York Structural Biology Laboratory , University of York , Heslington, York YO10 5DD , United Kingdom
| | | | | | - Wendy A Offen
- Department of Chemistry, York Structural Biology Laboratory , University of York , Heslington, York YO10 5DD , United Kingdom
| | | | | | | | | | | | - Gideon J Davies
- Department of Chemistry, York Structural Biology Laboratory , University of York , Heslington, York YO10 5DD , United Kingdom
| | | |
Collapse
|
12
|
Beenakker TJM, Wander DPA, Codée JDC, Aerts JMFG, van der Marel GA, Overkleeft HS. Synthesis of Carba-Cyclophellitols: a New Class of Carbohydrate Mimetics. European J Org Chem 2018. [DOI: 10.1002/ejoc.201701601] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Thomas J. M. Beenakker
- Department of Bio-Organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Dennis P. A. Wander
- Department of Bio-Organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Jeroen D. C. Codée
- Department of Bio-Organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Johannes M. F. G. Aerts
- Department of Medical Biochemistry; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Gijsbert A. van der Marel
- Department of Bio-Organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Herman S. Overkleeft
- Department of Bio-Organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| |
Collapse
|
13
|
Khoder ZM, Wong CE, Chemler SR. Stereoselective Synthesis of Isoxazolidines via Copper-Catalyzed Alkene Diamination. ACS Catal 2017; 7:4775-4779. [PMID: 29755827 DOI: 10.1021/acscatal.7b01362] [Citation(s) in RCA: 46] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
A convenient copper-catalyzed intramolecular/intermolecular alkene diamination reaction to synthesize 3-aminomethyl-functionalized isoxazolidines under mild reaction conditions and with generally high levels of diastereoselectivity was achieved. This reaction demonstrates that previously underutilized unsaturated carbamates are good [Cu]-catalyzed diamination substrates. Sulfonamides, anilines, benzamide, morpholine, and piperidine can serve as the external amine source. This relatively broad amine range is attributed to the mild reaction conditions. Reduction of the N-O bond could also be achieved, revealing the corresponding 3,4-diamino-1-alcohols efficiently.
Collapse
Affiliation(s)
- Zainab M. Khoder
- Department of Chemistry, The State University of New York at Buffalo, Buffalo, New York 14260, United States
| | - Christina E. Wong
- Department of Chemistry, The State University of New York at Buffalo, Buffalo, New York 14260, United States
| | - Sherry R. Chemler
- Department of Chemistry, The State University of New York at Buffalo, Buffalo, New York 14260, United States
| |
Collapse
|
14
|
Marques ARA, Willems LI, Herrera Moro D, Florea BI, Scheij S, Ottenhoff R, van Roomen CPAA, Verhoek M, Nelson JK, Kallemeijn WW, Biela-Banas A, Martin OR, Cachón-González MB, Kim NN, Cox TM, Boot RG, Overkleeft HS, Aerts JMFG. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease. Chembiochem 2017; 18:402-412. [DOI: 10.1002/cbic.201600561] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2016] [Indexed: 11/07/2022]
Affiliation(s)
- André R. A. Marques
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
- Present address: Institute of Biochemistry; Christian-Albrechts-University of Kiel; Otto-Hahn-Platz 9 24098 Kiel Germany
| | - Lianne I. Willems
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteeinweg 55 2300 RA Leiden The Netherlands
- Present address: Department of Chemistry; Simon Fraser University; 8888 University Drive Burnaby V5A 1S6 BC Canada
| | - Daniela Herrera Moro
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
| | - Bogdan I. Florea
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteeinweg 55 2300 RA Leiden The Netherlands
| | - Saskia Scheij
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
| | - Roelof Ottenhoff
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
| | - Cindy P. A. A. van Roomen
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
| | - Marri Verhoek
- Department of Biochemistry; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Jessica K. Nelson
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
| | - Wouter W. Kallemeijn
- Department of Biochemistry; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Anna Biela-Banas
- Institute of Organic and Analytical Chemistry; Université D'Orléans; Rue de Chartres B. P. 6759 45100 Orléans France
| | - Olivier R. Martin
- Institute of Organic and Analytical Chemistry; Université D'Orléans; Rue de Chartres B. P. 6759 45100 Orléans France
| | - M. Begoña Cachón-González
- Department of Medicine; University of Cambridge; Addenbrooke's Hospital; Hills Road Cambridge CB2 2QQ UK
| | - Nee Na Kim
- Department of Medicine; University of Cambridge; Addenbrooke's Hospital; Hills Road Cambridge CB2 2QQ UK
| | - Timothy M. Cox
- Department of Medicine; University of Cambridge; Addenbrooke's Hospital; Hills Road Cambridge CB2 2QQ UK
| | - Rolf G. Boot
- Department of Biochemistry; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Herman S. Overkleeft
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteeinweg 55 2300 RA Leiden The Netherlands
| | - Johannes M. F. G. Aerts
- Department of Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
- Department of Biochemistry; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2300 RA Leiden The Netherlands
| |
Collapse
|
15
|
Harit VK, Ramesh NG. A Chiron Approach to Diversity-Oriented Synthesis of Aminocyclitols, (−)-Conduramine F-4 and Polyhydroxyaminoazepanes from a Common Precursor. J Org Chem 2016; 81:11574-11586. [DOI: 10.1021/acs.joc.6b01790] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Vimal Kant Harit
- Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India
| | - Namakkal G. Ramesh
- Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India
| |
Collapse
|
16
|
Jiang J, Artola M, Beenakker TJM, Schröder SP, Petracca R, de Boer C, Aerts JMFG, van der Marel GA, Codée JDC, Overkleeft HS. The Synthesis of Cyclophellitol-Aziridine and Its Configurational and Functional Isomers. European J Org Chem 2016. [DOI: 10.1002/ejoc.201600472] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Jianbing Jiang
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Marta Artola
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Thomas J. M. Beenakker
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Sybrin P. Schröder
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Rita Petracca
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Casper de Boer
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Johannes M. F. G. Aerts
- Department of Medical Biochemistry; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Gijsbert A. van der Marel
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Jeroen D. C. Codée
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| | - Herman S. Overkleeft
- Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; Einsteinweg 55 2333 CC Leiden The Netherlands
| |
Collapse
|
17
|
Lamb JR, Mulzer M, LaPointe AM, Coates GW. Regioselective Isomerization of 2,3-Disubstituted Epoxides to Ketones: An Alternative to the Wacker Oxidation of Internal Alkenes. J Am Chem Soc 2015; 137:15049-54. [DOI: 10.1021/jacs.5b10419] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Jessica R. Lamb
- Department of Chemistry and
Chemical Biology, Baker Laboratory, Cornell University, Ithaca, New York 14853-1301, United States
| | - Michael Mulzer
- Department of Chemistry and
Chemical Biology, Baker Laboratory, Cornell University, Ithaca, New York 14853-1301, United States
| | - Anne M. LaPointe
- Department of Chemistry and
Chemical Biology, Baker Laboratory, Cornell University, Ithaca, New York 14853-1301, United States
| | - Geoffrey W. Coates
- Department of Chemistry and
Chemical Biology, Baker Laboratory, Cornell University, Ithaca, New York 14853-1301, United States
| |
Collapse
|
18
|
Chennamadhavuni D, Howell AR. A Solvent-free Approach to Glycosyl Amides: Towards the Synthesis of α- N-Galactosyl Ceramides. Tetrahedron Lett 2015; 56:3583-3586. [PMID: 26028787 DOI: 10.1016/j.tetlet.2015.02.133] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
A new, simple and efficient method for the synthesis of both α- and β-glycosyl amides using solvent-free conditions is described. This method involves the coupling of glycosyl amines with the p-nitrophenol esters of lipids as a key step.
Collapse
Affiliation(s)
| | - Amy R Howell
- Department of Chemistry, University of Connecticut, Storrs, CT 06269-3060
| |
Collapse
|
19
|
|
20
|
Jiang J, Kallemeijn WW, Wright DW, van den Nieuwendijk AMCH, Rohde VC, Folch EC, van den Elst H, Florea BI, Scheij S, Donker-Koopman WE, Verhoek M, Li N, Schürmann M, Mink D, Boot RG, Codée JDC, van der Marel GA, Davies GJ, Aerts JMFG, Overkleeft HS. In vitro and in vivo comparative and competitive activity-based protein profiling of GH29 α-l-fucosidases. Chem Sci 2015; 6:2782-false. [PMID: 29142681 PMCID: PMC5654414 DOI: 10.1039/c4sc03739a] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2014] [Accepted: 02/09/2015] [Indexed: 01/07/2023] Open
Abstract
GH29 α-l-fucosidases catalyze the hydrolysis of α-l-fucosidic linkages. Deficiency in human lysosomal α-l-fucosidase (FUCA1) leads to the recessively inherited disorder, fucosidosis. Herein we describe the development of fucopyranose-configured cyclophellitol aziridines as activity-based probes (ABPs) for selective in vitro and in vivo labeling of GH29 α-l-fucosidases from bacteria, mice and man. Crystallographic analysis on bacterial α-l-fucosidase confirms that the ABPs act by covalent modification of the active site nucleophile. Competitive activity-based protein profiling identified l-fuconojirimycin as the single GH29 α-l-fucosidase inhibitor from eight configurational isomers.
Collapse
Affiliation(s)
- Jianbing Jiang
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Wouter W Kallemeijn
- Department of Medical Biochemistry , Academic Medical Center , Meibergdreef 15 , 1105 AZ Amsterdam , The Netherlands
| | - Daniel W Wright
- Department of Chemistry , University of York , Heslington , York , YO10 5DD , UK
| | | | - Veronica Coco Rohde
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Elisa Colomina Folch
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Hans van den Elst
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Bogdan I Florea
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Saskia Scheij
- Department of Medical Biochemistry , Academic Medical Center , Meibergdreef 15 , 1105 AZ Amsterdam , The Netherlands
| | - Wilma E Donker-Koopman
- Department of Medical Biochemistry , Academic Medical Center , Meibergdreef 15 , 1105 AZ Amsterdam , The Netherlands
| | - Marri Verhoek
- Department of Medical Biochemistry , Academic Medical Center , Meibergdreef 15 , 1105 AZ Amsterdam , The Netherlands
| | - Nan Li
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Martin Schürmann
- DSM Innovative Synthesis , Urmonderbaan 22 , NL-6167 RD Geleen , The Netherlands
| | - Daniel Mink
- DSM Innovative Synthesis , Urmonderbaan 22 , NL-6167 RD Geleen , The Netherlands
| | - Rolf G Boot
- Department of Medical Biochemistry , Academic Medical Center , Meibergdreef 15 , 1105 AZ Amsterdam , The Netherlands
| | - Jeroen D C Codée
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Gijsbert A van der Marel
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| | - Gideon J Davies
- Department of Chemistry , University of York , Heslington , York , YO10 5DD , UK
| | - Johannes M F G Aerts
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ; .,Department of Medical Biochemistry , Academic Medical Center , Meibergdreef 15 , 1105 AZ Amsterdam , The Netherlands
| | - Herman S Overkleeft
- Leiden Institute of Chemistry , Leiden University , P. O. Box 9502 , 2300 RA Leiden , The Netherlands . ;
| |
Collapse
|
21
|
Alcaide A, Trapero A, Pérez Y, Llebaria A. Galacto configured N-aminoaziridines: a new type of irreversible inhibitor of β-galactosidases. Org Biomol Chem 2015; 13:5690-7. [DOI: 10.1039/c5ob00532a] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
N-Aminoaziridines are potent irreversible inhibitors of galactosidases.
Collapse
Affiliation(s)
- Anna Alcaide
- Medicinal Chemistry Laboratory (MedChemLab)
- Departament de Química Biomèdica
- Institut de Química Avançada de Catalunya (IQAC–CSIC)
- Barcelona
- Spain
| | - Ana Trapero
- Medicinal Chemistry Laboratory (MedChemLab)
- Departament de Química Biomèdica
- Institut de Química Avançada de Catalunya (IQAC–CSIC)
- Barcelona
- Spain
| | - Yolanda Pérez
- NMR Unit
- Institut de Química Avançada de Catalunya (IQAC–CSIC)
- Barcelona
- Spain
| | - Amadeu Llebaria
- Medicinal Chemistry Laboratory (MedChemLab)
- Departament de Química Biomèdica
- Institut de Química Avançada de Catalunya (IQAC–CSIC)
- Barcelona
- Spain
| |
Collapse
|
22
|
Willems LI, Beenakker TJM, Murray B, Gagestein B, van den Elst H, van Rijssel ER, Codée JDC, Kallemeijn WW, Aerts JMFG, van der Marel GA, Overkleeft HS. Synthesis of α- and β-Galactopyranose-Configured Isomers of Cyclophellitol and Cyclophellitol Aziridine. European J Org Chem 2014. [DOI: 10.1002/ejoc.201402589] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
23
|
Ji L, Zhou GQ, Qian C, Chen XZ. Synthesis of 1,2,3-Triazoles from Azide-Derivatised Aminocyclitols by Catalytic Diazo Transfer and CuAAC Click Chemistry. European J Org Chem 2014. [DOI: 10.1002/ejoc.201301874] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
24
|
Alcaide A, Llebaria A. Aziridine Ring Opening for the Synthesis of Sphingolipid Analogues: Inhibitors of Sphingolipid-Metabolizing Enzymes. J Org Chem 2014; 79:2993-3029. [DOI: 10.1021/jo500061w] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- Anna Alcaide
- Medicinal Chemistry Laboratory (MedChemLab), Departament
de Química Biomèdica, Institut de Química Avançada de Catalunya (IQAC−CSIC), Jordi Girona 18-26, Barcelona 08034, Spain
| | - Amadeu Llebaria
- Medicinal Chemistry Laboratory (MedChemLab), Departament
de Química Biomèdica, Institut de Química Avançada de Catalunya (IQAC−CSIC), Jordi Girona 18-26, Barcelona 08034, Spain
| |
Collapse
|
25
|
Laurent X, Bertin B, Renault N, Farce A, Speca S, Milhomme O, Millet R, Desreumaux P, Hénon E, Chavatte P. Switching Invariant Natural Killer T (iNKT) Cell Response from Anticancerous to Anti-Inflammatory Effect: Molecular Bases. J Med Chem 2014; 57:5489-508. [DOI: 10.1021/jm4010863] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Xavier Laurent
- Faculté
de Médecine, Intestinal Biotech Development, Amphis J et K, Boulevard du Professeur Jules Leclerc, 59045 Lille Cedex, France
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Benjamin Bertin
- Faculté
de
Médecine, Université Lille-Nord de France, Amphis J
et K, INSERM U995, Boulevard du Professeur
Jules Leclerc, 59045 Lille Cedex, France
| | - Nicolas Renault
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Amaury Farce
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Silvia Speca
- Faculté
de
Médecine, Université Lille-Nord de France, Amphis J
et K, INSERM U995, Boulevard du Professeur
Jules Leclerc, 59045 Lille Cedex, France
| | - Ophélie Milhomme
- Institut
de Chimie Pharmaceutique Albert Lespagnol, EA 4481, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Régis Millet
- Institut
de Chimie Pharmaceutique Albert Lespagnol, EA 4481, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Pierre Desreumaux
- Faculté
de
Médecine, Université Lille-Nord de France, Amphis J
et K, INSERM U995, Boulevard du Professeur
Jules Leclerc, 59045 Lille Cedex, France
| | - Eric Hénon
- Université
de Reims Champagne-Ardenne, UFR des Sciences Exactes et Naturelles,
BSMA-ICMR, UMR CNRS 6229, Moulin de
la Housse, BP 1039, 51687 Reims Cedex 2, France
| | - Philippe Chavatte
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
- Institut
de Chimie Pharmaceutique Albert Lespagnol, EA 4481, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| |
Collapse
|
26
|
Herndon JW. The chemistry of the carbon-transition metal double and triple bond: Annual survey covering the year 2011. Coord Chem Rev 2013. [DOI: 10.1016/j.ccr.2013.05.011] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
27
|
|
28
|
Griffen JA, White JC, Kociok-Köhn G, Lloyd MD, Wells A, Arnot TC, Lewis SE. New aminocyclitols with quaternary stereocentres via acylnitroso cycloaddition with an ipso,ortho arene dihydrodiol. Tetrahedron 2013. [DOI: 10.1016/j.tet.2013.04.033] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
29
|
Morandi B, Wickens ZK, Grubbs RH. Practical and general palladium-catalyzed synthesis of ketones from internal olefins. Angew Chem Int Ed Engl 2013; 52:2944-8. [PMID: 23325587 DOI: 10.1002/anie.201209541] [Citation(s) in RCA: 82] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2012] [Indexed: 11/09/2022]
Affiliation(s)
- Bill Morandi
- Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA
| | | | | |
Collapse
|
30
|
Morandi B, Wickens ZK, Grubbs RH. Practical and General Palladium-Catalyzed Synthesis of Ketones from Internal Olefins. Angew Chem Int Ed Engl 2013. [DOI: 10.1002/ange.201209541] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
31
|
East JE, Kennedy AJ, Webb TJ. Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells. Med Res Rev 2012; 34:45-76. [PMID: 23239102 DOI: 10.1002/med.21276] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Natural killer T (NKT) cells serve as a bridge between the innate and adaptive immune systems, and manipulating their effector functions can have therapeutic significances in the treatment of autoimmunity, transplant biology, infectious disease, and cancer. NKT cells are a subset of T cells that express cell-surface markers characteristic of both natural killer cells and T cells. These unique immunologic cells have been demonstrated to serve as a link between the innate and adaptive immune systems through their potent cytokine production following the recognition of a range of lipid antigens, mediated through presentation of the major histocompatibility complex (MHC) class I like CD1d molecule, in addition to the NKT cell's cytotoxic capabilities upon activation. Although a number of glycolipid antigens have been shown to complex with CD1d molecules, most notably the marine sponge derived glycolipid alpha-galactosylceramide (α-GalCer), there has been debate as to the identity of the endogenous activating lipid presented to the T-cell receptor (TCR) via the CD1d molecule on antigen-presenting cells (APCs). This review aims to survey the use of pharmacological agents and subsequent structure-activity relationships (SAR) that have given insight into the binding interaction of glycolipids with both the CD1d molecules as well as the TCR and the subsequent immunologic response of NKT cells. These studies not only elucidate basic binding interactions but also pave the way for future pharmacological modulation of NKT cell responses.
Collapse
Affiliation(s)
- James E East
- Department of Microbiology and Immunology, The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201
| | | | | |
Collapse
|
32
|
Liu Z, Courtney AN, Metelitsa LS, Bittman R. C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes. Chembiochem 2012; 13:1733-7. [PMID: 22782839 DOI: 10.1002/cbic.201200374] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2012] [Indexed: 01/29/2023]
Affiliation(s)
- Zheng Liu
- Department of Chemistry and Biochemistry, Queens College of The City University of New York, Flushing, NY 11367, USA
| | | | | | | |
Collapse
|
33
|
Hsieh MH, Hung JT, Liw YW, Lu YJ, Wong CH, Yu AL, Liang PH. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation. Chembiochem 2012; 13:1689-97. [PMID: 22730199 DOI: 10.1002/cbic.201200004] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2012] [Indexed: 12/25/2022]
Abstract
α-GalCer is an immunostimulating glycolipid that binds to CD1d molecules and activates invariant natural killer T (iNKT) cells. Here we report a scaled-up synthesis of α-GalCer analogues with modifications in the acyl side chain and/or at the galactose 6''-position, together with their evaluation in vitro and in vivo. Analogues containing 11-phenylundecanoyl acyl side chains with aromatic substitutions (14, 16-21) and Gal-6''-phenylacetamide-substituted α-GalCer analogues bearing p-nitro- (32), p-tert-butyl (34), or o-, m-, or p-methyl groups (40-42) displayed higher IFN-γ/IL-4 secretion ratios than α-GalCer in vitro. In mice, compound 16, with an 11-(3,4-difluorophenyl)undecanoyl acyl chain, induced significant proliferation of NK and DC cells, which should be beneficial in killing tumors and priming the immune response. These new glycolipids might prove useful as adjuvants or anticancer agents.
Collapse
Affiliation(s)
- Ming-Han Hsieh
- School of Pharmacy, College of Medicine, National Taiwan University, 1, Jen-Ai Road, Section 1, Taipei 100, Taiwan
| | | | | | | | | | | | | |
Collapse
|
34
|
Abstract
The 1,2-diamine moiety is a ubiquitous structural motif present in a wealth of natural products, including non-proteinogenic amino acids and numerous alkaloids, as well as in pharmaceutical agents, chiral ligands and organic reagents. The biological activity associated with many of these systems and their chemical utility in general has ensured that the development of methods for their preparation is of critical importance. While a wide range of strategies for the preparation of 1,2-diamines have been established, the diamination of alkenes offers a particularly direct and efficient means of accessing these systems. The purpose of this review is to provide an overview of all methods of direct alkene diamination, metal-mediated or otherwise.
Collapse
Affiliation(s)
- Sam de Jong
- Department of Chemistry, University of Illinois at Chicago, 845 West Taylor Street, Chicago, IL, 60607-7061 USA
| | - Daniel G. Nosal
- Department of Chemistry, University of Illinois at Chicago, 845 West Taylor Street, Chicago, IL, 60607-7061 USA
| | - Duncan J. Wardrop
- Department of Chemistry, University of Illinois at Chicago, 845 West Taylor Street, Chicago, IL, 60607-7061 USA
| |
Collapse
|
35
|
Regioselectivity in the ring opening of epoxides for the synthesis of aminocyclitols from D-(-)-quinic acid. Molecules 2012; 17:4498-507. [PMID: 22508330 PMCID: PMC6268476 DOI: 10.3390/molecules17044498] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2012] [Revised: 04/09/2012] [Accepted: 04/10/2012] [Indexed: 11/21/2022] Open
Abstract
Efficient syntheses of four aminocyclitols are reported. Each synthesis is accomplished in eight steps starting from D-(−)-quinic acid. The key step involves a highly regioselective ring opening of epoxides by sodium azide.
Collapse
|
36
|
Patel O, Cameron G, Pellicci DG, Liu Z, Byun HS, Beddoe T, McCluskey J, Franck RW, Castaño AR, Harrak Y, Llebaria A, Bittman R, Porcelli SA, Godfrey DI, Rossjohn J. NKT TCR recognition of CD1d-α-C-galactosylceramide. THE JOURNAL OF IMMUNOLOGY 2011; 187:4705-13. [PMID: 21964029 DOI: 10.4049/jimmunol.1100794] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
NKT cells respond to a variety of CD1d-restricted glycolipid Ags that are structurally related to the prototypic Ag α-galactosylceramide (α-GalCer). A modified analog of α-GalCer with a carbon-based glycosidic linkage (α-C-GalCer) has generated great interest because of its apparent ability to promote prolonged, Th1-biased immune responses. In this study, we report the activation of spleen NKT cells to α-C-GalCer, and related C-glycoside ligands, is weaker than that of α-GalCer. Furthermore, the Vβ8.2 and Vβ7 NKT TCR affinity for CD1d-α-C-GalCer, and some related analogs, is ∼10-fold lower than that for the NKT TCR-CD1d-α-GalCer interaction. Nevertheless, the crystal structure of the Vβ8.2 NKT TCR-CD1d-α-C-GalCer complex is similar to that of the corresponding NKT TCR-CD1d-α-GalCer complex, although subtle differences at the interface provide a basis for understanding the lower affinity of the NKT TCR-CD1d-α-C-GalCer interaction. Our findings support the concept that for CD1d-restricted NKT cells, altered glycolipid ligands can promote markedly different responses while adopting similar TCR-docking topologies.
Collapse
Affiliation(s)
- Onisha Patel
- Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|